TAK

Takeda Pharmaceutical Company Limited
D

TAK

13.330
USD
0.05
(0.38%)
مغلق
حجم التداول
110,382
الربح لكل سهم
136
العائد الربحي
4.2
P/E
44
حجم السوق
42,238,354,919
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    -12.22
    (-4.13%)
    289.88 USD
    AZN
    AZN
    -1.830
    (-2.81%)
    64.255 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    749.9 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.85 USD
    NVO
    NVO
    -3.620
    (-3.44%)
    102.64 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.14 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    SNY
    SNY
    0.160
    (0.33%)
    47.975 USD
    المزيد
الأخبار

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.